The agreement will give patients access to Vertex's Orkambi and Symkevi as treatment options.
Vertex cystic fibrosis medicines are reimbursed in 17 countries including Austria, Australia, Denmark, Germany, the Republic of Ireland, Italy, the Netherlands, Sweden and the US.
Price: 173.11, Change: +2.10, Percent Change: +1.23
|Forex Update: USD/CAD Prints Low at 1.3071|
|SITE Centers Prices Stock Offering at 2.5% Discount|
|Market Chatter: UBS, Piper Jaffray Cut Staff at Ener...|
|FDA Approves Kadmon Holdings' Clovique for Treatment...|
|LCI Industries Acquires SureShade for Undisclosed Sum|